Work

Abstract LB232: Deciphering novel MRTF-A inhibitors and combination strategies for HCC therapy

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-lb232

Authors: Miriam Jasmin Franz, Laura Rupprecht, Pia Wenisch, Petra Wohlleben, Vladimir Chubanov, Thomas Gudermann, Salla Kyheröinen, Achim Aigner, Maria Kristina Vartiainen, Markus Heinrich, Susanne Mühlich

Institutions: Friedrich-Alexander-Universität Erlangen-Nürnberg, Walther-Straub-Institut für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität München, University of Helsinki, HiLIFE – Elämäntieteiden Instituutti, Leipzig University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409821902

Cites:

Cited by:

Related to: 10